| 000 | 01499 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512210701.0 | ||
| 264 | 0 | _c19830527 | |
| 008 | 198305s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19830501)51:9<1587::aid-cncr2820510906>3.0.co;2-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiben, P D | |
| 245 | 0 | 0 |
_aReduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy. _h[electronic resource] |
| 260 |
_bCancer _cMay 1983 |
||
| 300 |
_a1587-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAgranulocytosis _xdrug therapy |
| 650 | 0 | 4 |
_aBacterial Infections _xmortality |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMortality |
| 650 | 0 | 4 |
_aNeutropenia _xdrug therapy |
| 650 | 0 | 4 |
_aSulfamethoxazole _xtherapeutic use |
| 650 | 0 | 4 |
_aTrimethoprim _xtherapeutic use |
| 700 | 1 | _aLouie, T J | |
| 700 | 1 | _aLank, B A | |
| 700 | 1 | _aKornachuk, E | |
| 700 | 1 | _aGurwith, M J | |
| 700 | 1 | _aHarding, G K | |
| 700 | 1 | _aRonald, A R | |
| 773 | 0 |
_tCancer _gvol. 51 _gno. 9 _gp. 1587-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19830501)51:9<1587::aid-cncr2820510906>3.0.co;2-0 _zAvailable from publisher's website |
| 999 |
_c6338949 _d6338949 |
||